Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial

Published:2019-09 Issue:7 Volume:15 Page:603-606
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Kerkmeijer Laura S.M.,Tijssen Ruben Yannick G.,Hofma Sjoerd H.,van der Schaaf Rene J.,Arkenbout Karin E.,Kraak Robin P.,Weevers Auke,Piek Jan J.,de Winter Robbert J.,Tijssen Jan G.P.,Henriques Jose P.S.,Wykrzykowska Joanna J.,Ijsselmuiden Alexander,Kauer Floris,Beijk Marcel A.,Vis Marije,Koch Karel

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

2. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside;Cardiovascular Research;2022-07-05

3. Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial;EuroIntervention;2022-03

4. ImpaCt of an Optimal Implantation Strategy on Absorb Long-Term Outcomes: The CIAO Registry;Cardiovascular Revascularization Medicine;2021-09

5. Bioresorbable vascular scaffolds in the routine clinical practice: long-term results;REC: interventional cardiology (English Edition);2021-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP